Literature DB >> 16224049

Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase.

Woo Je Lee1, In Kyu Lee, Hyoun Sik Kim, Yun Mi Kim, Eun Hee Koh, Jong Chul Won, Sung Min Han, Min-Seon Kim, Inho Jo, Goo Taeg Oh, In-Sun Park, Jang Hyun Youn, Seong-Wook Park, Ki-Up Lee, Joong-Yeol Park.   

Abstract

OBJECTIVE: Lipid accumulation in vascular endothelial cells may play an important role in the pathogenesis of atherosclerosis in obese subjects. We showed previously that alpha-lipoic acid (ALA) activates AMP-activated protein kinase (AMPK) and reduces lipid accumulation in skeletal muscle of obese rats. Here, we investigated whether ALA improves endothelial dysfunction in obese rats by activating AMPK in endothelial cells. METHODS AND
RESULTS: Endothelium-dependent vascular relaxation was impaired, and the number of apoptotic endothelial cells was higher in the aorta of obese rats compared with control rats. In addition, triglyceride and lipid peroxide levels were higher, and NO synthesis was lower. Administration of ALA improved all of these abnormalities. AMPK activity was lower in aortic endothelium of obese rats, and ALA normalized it. Incubation of human aortic endothelial cells with ALA activated AMPK and protected cells from linoleic acid-induced apoptosis. Dominant-negative AMPK inhibited the antiapoptotic effects of ALA.
CONCLUSIONS: Reduced AMPK activation may play an important role in the genesis of endothelial dysfunction in obese rats. ALA improves vascular dysfunction by normalizing lipid metabolism and activating AMPK in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224049     DOI: 10.1161/01.ATV.0000190667.33224.4c

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells.

Authors:  E D Targonsky; F Dai; V Koshkin; G T Karaman; A V Gyulkhandanyan; Y Zhang; C B Chan; M B Wheeler
Journal:  Diabetologia       Date:  2006-05-13       Impact factor: 10.122

2.  Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells.

Authors:  Jessica Deslauriers; Christian Desmarais; Philippe Sarret; Sylvain Grignon
Journal:  J Mol Neurosci       Date:  2013-11-08       Impact factor: 3.444

Review 3.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 4.  AMPK inhibition in health and disease.

Authors:  Benoit Viollet; Sandrine Horman; Jocelyne Leclerc; Louise Lantier; Marc Foretz; Marc Billaud; Shailendra Giri; Fabrizio Andreelli
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-08       Impact factor: 8.250

Review 5.  AMP-activated protein kinase and metabolic control.

Authors:  Benoit Viollet; Fabrizio Andreelli
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Lipoic acid attenuates the expression of adhesion molecules by increasing endothelial nitric-oxide synthase activity.

Authors:  Hong-Bo Jin; Yong-Bin Yang; Ying-Li Song; Yong-Chun Zhang; Yu-Rong Li
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 7.  Role of the energy sensor AMP-activated protein kinase in renal physiology and disease.

Authors:  Kenneth R Hallows; Peter F Mount; Núria M Pastor-Soler; David A Power
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-24

8.  Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels.

Authors:  Nam Ho Jeoung; Robert A Harris
Journal:  Korean Diabetes J       Date:  2010-10-31

9.  Lipoic acid significantly restores, in rats, the age-related decline in vasomotion.

Authors:  A R Smith; F Visioli; B Frei; T M Hagen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

10.  In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2009-06-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.